Effect of processing time on analysis of rare event in minimal residual disease study
Editor, Rare event analysis was started with the analysis of the fetal red blood cells in maternal circulation in a rare percentage. [1, 2] Flow cytometry (FCM) has been used to analyze numerous rare cell populations in blood or bone marrow from circulating endothelial cells to cancer stem cells and became an important means in analysis of blood cancer. [2] [3] [4] [5] [6] [7] Initially, FCM was used only for lineage deciding in leukemia; but by years, it was developed for morphological assessment of blood and bone marrow to detect minimal residual disease (MRD), with molecular analysis used in treatment decisions of pediatric B-acute lymphoblastic leukemia and more recently acute myeloid leukemia. [8] [9] [10] [11] [12] [13] The FCM is helpful in the detection of small tumor population to the level of 0.01% in lymph proliferative disorders. [9, 10] MRD detection has been associated with time to relapse in the acute leukemia; [8, [9] [10] [11] 13] there are several technical and interpretative hurdles that need to be addressed before a laboratory undertakes such an analysis. For acute myeloid leukemia (AML), there are few well-validated protocols, and this is complicated by the fact that this disease is often composed of multiple clones at presentation and can be affected by antigen modulation during treatment. [10, 11] In MRD, the time of sample processing in the rare event analysis was important because cells were very less (>0.01%) so it was important to correlate the time to get maximum number of cells and also validate staining procedure and fluorochrome. A total of four AML MRD processed samples were used in the study, previously diagnosed for AML on morphology. Immunophenotyping done at Lab Oncology, Dr. BRAICH, All India Institute of Medical Sciences, New Delhi. For flow cytometric analysis, at least 200,000 were acquired at follow-up in all cases from each tube, and data were stored in list mode. The procedure was repeated after 15 h, and data were collected. For all the specimens, five-color FCM was performed on Coulter FC500 instrument (Beckman Coulter [BC], Hialeah, FL, USA). Combinations of 5 antibodies in 7 different tubes, After 15 hours, significant loss in the rare events was observed. S/N ratio: Signal-to-noise ratio; MFI: Mean fluorescence intensity with CD34 and CD45 as backbone markers was used for analysis. The antibody panel used is shown in Table 1 . The instrument setup was done by Flow Check fluorospheres (BC, Hialeah, FL, USA) for alignment, Flow Set beads (BC, Hialeah, FL, USA) for voltage standardization, and compensation was also done. Alignment was done on a daily basis to ensure precise flow of cells through the laser beam intersection and the fluid stream so that each detector gave maximal and reproducible signals from the standard particles or cells. Electronic standardization (voltage and compensation) also ensured that results were reproducible on a daily basis. The same instrument settings were used for samples.
For data analysis, Boolean logic gating was used to identify the leukemia-associated immunophenotypes (LAIPs) at the time of diagnosis and at the time of MRD quantification in the postinduction marrow. Gating strategy includes the debris exclusion by time gate (for taking continuous sample stream) and then the SYTO 41 was used to exclude the dead cells from nucleated live cells, on which singlet gate was formed to include only single cells not doublets. These singlet cells were further used for analysis. On CD45/SS plot, at intermediate/low side scatter region, a gate was formed, followed by back gating on the CD34+ population and removal of CD19+ hematogones from analysis. These cells with different parameter were used to identify LAIP, and in the study, the percentage variation of these cells was correlated. Cleaning of the instrument is crucial step to reduce background level of noise below the threshold that would interfere the rare events. For identification of rare event accuracy and eliminating background noise, staining buffer was acquired before sample acquisition and number of events noted down, and then test sample stained with AML panel was is acquired for events that are detectable in the region of interest. This exercise should be performed periodically or any time when there is an unexpected result. It is important to acquire a saline or sheath fluid before MRD collection to ensure no carryover is there. The rare event analysis was done on the processed sample for AML MRD after 15 h to check the reduction in the percentage of the rare events noted earlier and also the change in mean fluorescence intensity [MFI] [ Figure 1 ].
Our result is shown in Table 1 , shows reduction in MFI and percent loss of cells when samples were processed within 4 hours and after 15 hours. As noted, there was a significant loss of cells and reduction in MFI with time in all plots of CD56/34, CD7/34 and CD14/34. So to conclude, we could advise the feasibility and applicability of MRD estimation by flow cytometry on the fresh sample within 4 hours of reciept as compared to the long standing diagnostic samples to ensure accurate and true results.
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Helicobacter pylori prevalence and relation with obesity
Editor, We have read with great interest recently published paper of Saha et al., "Application of a stool antigen test to evaluate the burden of Helicobacter pylori infection in dyspepsia patients." [1] They recommend initial testing for H. pylori stool antigen in dyspeptic patients before initiating treatment and before carrying out any invasive procedure such as endoscopy.
We also tested stool samples in Turkish patients to find out if H. pylori positivity is a risk factor for obesity. Recent studies about the relationship between H. pylori and insulin resistance and obesity has conflicting results such as some of them state that H. pylori prevalence is high in obese people; others state that H. pylori eradication increases obesity.
The prevalence of H. pylori changes to 44%-70% in Turkey where 30.4% of population is obese. [2, 3] There was no significant relation between antigen positivity and having gastrointestinal complaints (for each symptom P > 0.05).
Lender et al. [4] have showed the inverse relation of obesity and H. pylori infection while Thjodleifsson et al. [5] have claimed a significant correlation between them. In a study from Turkey, H. pylori prevalence was 57.2% in obese and 27.0% in control group (P < 0.001) suggested that obesity could be a risk factor for H. pylori infection whereas we could not confirm this result in our study. [6] Financial support and sponsorship Nil.
Conflicts of interest
There are no conflicts of interest.
Saime Hacer Ozdemir, Çagrı Aksu, Ebru Ozden, Irem Narman, Seda Varlik, Burak Aksu 1 , Ozgur Kasimay 2 , Aysegul Karahasan Yagci 1
